New mRNA vaccine could reduce the recurrence and spread of skin cancer

NPR | By Leila Fadel

Published August 20, 2026 at 3:45 AM CDT

Facebook
Twitter
LinkedIn
Email

Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.

Facebook
Twitter
LinkedIn
Email

Leila Fadel

Leila Fadel is a host of Morning Edition, as well as NPR's morning news podcast Up First.

See stories by Leila Fadel

Public media depends on you.

Your support keeps Prairie Public strong and independent, serving communities across our region with programs that educate, involve, and inspire.

Donate